BioSpace News Archive

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company’s investor webcast to review third-quarter 2021 financials and provide business updates will take place at 8:30 a.m. Eastern Time on Wednesday, November 17, 2021 instead of today.

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today gave an update on the company’s development project ND3014.

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology therapeutics, announced that members of the senior management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, taking place on Monday, November 29 – Thursday, December 2, 2021.

LogicBio Therapeutics, Inc., a clinical-stage genetic medicine company, reported financial results for the third quarter ended September 30, 2021 and highlighted recent corporate milestones.

Catamaran Bio, Inc., a biotechnology company developing off-the-shelf CAR-NK cell therapies to treat cancer, announced the appointment of Tara Place, MBA, as Vice President, Human Resources and Organizational Effectiveness.

Castle Biosciences Named a 2021 Houston Chronicle Top Workplace

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

Pharma-Bio Serv, Inc. today announced that the Board of Directors approved a Special Dividend of $0.075 per share for Shareholders.

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

Pluristem Therapeutics Inc. announced today that its multinational Phase IIImulticenter, randomized, double-blind, placebo-controlled study, designed to determine the efficacy, safety, and tolerability of intramuscular administration of allogeneic PLX-PAD cells for the treatment of muscle injury following arthroplasty for hip fracture, is fully enrolled with 240 patients.